Soligenix completes phase 1 study for pediatric Crohn's disease treatment

[nogutsnoglory]

"Soligenix, a clinical stage bipharmaceutical company, said today it has enrolled and treated all the patients in its phase 1 study for SGX203 - one of its main product candidates and a potential treatment for pediatric Crohn's disease..."

http://www.proactiveinvestors.com.a...pediatric-crohns-disease-treatment-45118.html